Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Eli Lilly (NY: LLY)
137.93 USD  +3.82 (+2.85%)
Streaming Delayed Price  /  Updated: 2:22 PM EDT, Mar 30, 2020  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 3,050,527
Open 133.87
Bid (Size) 137.86 (2)
Ask (Size) 137.95 (2)
Prev. Close 134.11
Today's Range 133.51 - 141.77
52wk Range 101.36 - 147.87
Shares Outstanding 1,085,430,420
Dividend Yield 1.63%
Performance
YTD
+4.33%
+4.33%
1 Month
+9.36%
+9.36%
3 Month
+5.05%
+5.05%
6 Month
+23.34%
+23.34%
1 Year
+6.88%
+6.88%
Top News
More News
Lilly's Taltz® (ixekizumab) Receives U.S. FDA Approval for the Treatment of Pediatric Patients with Moderate to Severe Plaque Psoriasis
-- Taltz is the first and only IL-17A antagonist approved to treat this population -- Read More
from PR Newswire
Updates from Lilly about insulin supply and affordability
To keep the diabetes community informed about important developments from the COVID-19 crisis, Eli Lilly and Company (NYSE: LLY) today is providing updates related to insulin supply and affordability: Read More
from PR Newswire
More News
Read More
Lilly Provides Update on Clinical Trial Activities During COVID-19 Pandemic
from PR Newswire
Lilly to Provide Drive-Through COVID-19 Testing for Indianapolis Health Care Workers
from PR Newswire
Notable ETF Inflow Detected - FTCS, PGR, LLY, AMGN
category ETFs
from ETF Channel
Why Eli Lilly's Stock Is Trading Higher Today
category News , Trading Ideas , FDA , and 5 more.
from Benzinga
Drug makers on shaky ground as clinical trials are postponed and drug launches delayed amid pandemic
category MYL , XBI , Medical Products , and 10 more.
from MarketWatch
Drugmaker Vertex to delay new clinical studies due to coronavirus
category companyNews
from Reuters: Company News
Veeva Systems' CRM Product Is Seeing Ten Times More Usage During Coronavirus Pandemic
category MSFT , BIIB , LLY , and 15 more.
from Benzinga
UPDATE 1-U.S. drugmaker Pfizer pauses new studies due to coronavirus pandemic
category companyNews
from Reuters: Company News
Better Buy: Geron vs. Acceleron
category Market News , GERN , INCY , and 3 more.
from Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.